Vivodyne launches with $38M to create lab-grown human organs
The company will use the funds to grow its drug-discovery pipeline and clinical AI stack.
Stay updated with breaking news from Molecular Space. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The company will use the funds to grow its drug-discovery pipeline and clinical AI stack.
The Healthtech Times is a weekly newsletter covering healthtech news from Canada and around the globe.
Genesis Therapeutics recently joined the growing list of AI-powered drug discovery startups receiving venture funding this year. The company closed a $200 million Series B financing round, taking its total funding to date to more than $280 million.
The company will use the funds to bring its AI-enabled offerings into clinical development and advance its platform and portfolio.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!